AN2 Therapeutics, Inc. ($ANTX)
Filing Information
| Accession Number | 0001193125-26-357225 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 19, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
35,402
Total Value
$212,702.30
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Aug 17, 2026 | Sale | 16,696 | $6.01 | $100,312.91 | 565,592 | Indirect | See footnotes | View Details | |
Director | Common Stock | โ | Aug 17, 2026 | Sale | 18,706 | $6.01 | $112,389.39 | 633,867 | Indirect | See footnotes | View Details |